The Endometriosis CARE Act, introduced in 2022, aims to provide $50 million annually for research and expanded access to treatment for endometriosis. This condition involves tissue similar to the uterine lining growing outside the uterus, causing pain, heavy periods, and potential fertility issues. Affecting more than one in ten reproductive-age women, there is currently no known cure.
Jessica Opoku-Anane, an associate professor at Rutgers Robert Wood Johnson Medical School specializing in endometriosis and minimally invasive surgery, highlighted the significance of this funding. “The Endometriosis Care Act could be one of the best things that has happened for people with endometriosis in a long time,” she stated. She emphasized the lack of research and education on endometriosis and noted that this act would support women’s health research.
Opoku-Anane pointed out that there are many unknowns about endometriosis due to insufficient research funding. Questions remain about which treatments work best for different patients or who might develop severe symptoms or infertility.
The cause of endometriosis is unclear due to limited research. It is understood as more than just tissue growth outside the uterus; it affects those who do not menstruate and is considered a systemic disorder involving hormone and immune system dysregulation influenced by genetics and environment.
Endometriosis often goes misunderstood and misdiagnosed, with an average delay of nine years from symptom onset to diagnosis. Opoku-Anane cited several reasons for this delay: normalization of pain in women, familial tendencies leading patients to consider their pain normal, irregular menstrual cycles in adolescents masking symptoms, and atypical presentations overlooked in medical education.
Current treatments aim to manage symptoms since there is no cure. These include regulating estrogen levels or surgical options like excision or ablation. Excision is favored as it removes more of the disease’s root causes.
There is a known association between endometriosis and a higher risk of ovarian cancer, particularly with ovarian endometriomas or cyst-related cases.
Opoku-Anane also addressed disparities in treatment among adolescents experiencing chronic pain without other diagnoses being ruled out first. Additionally, racial minorities and lower-income patients face barriers accessing specialists due to normalized pain perceptions within these groups.
